Hans Ebbers

Hans Ebbers is a seasoned professional in clinical development and regulatory affairs, currently serving as the Clinical Development Lead at Alvotech since July 2025. Previously, Hans held various leadership positions at Biogen from June 2017 to July 2025, including Director Clinical Science and Associate Director Clinical Science in the Biosimilars division, where responsibilities encompassed driving R&D strategies and overseeing regulatory submissions. Prior experience includes roles as a Regulatory Project Leader at the College ter Beoordeling van Geneesmiddelen and Senior Manager of Regulatory Affairs at Samsung Bioepis. Hans's academic background includes a PhD in Pharmaceutical Sciences from Utrecht University and MSc degrees in Biomedical Sciences and Medical Biology from the University of Amsterdam and Vrije Universiteit Amsterdam, respectively.